Myriad Genetics
MYGN
MYGN
197 hedge funds and large institutions have $1.13B invested in Myriad Genetics in 2022 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 73 increasing their positions, 66 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1.54% less ownership
Funds ownership: 101.06% → 99.52% (-1.5%)
27% less capital invested
Capital invested by funds: $1.55B → $1.13B (-$423M)
Holders
197
Holding in Top 10
–
Calls
$1.31M
Puts
$43K
Top Buyers
| 1 | +$29M | |
| 2 | +$23.7M | |
| 3 | +$12M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$5.49M |
| 5 |
State Street
Boston,
Massachusetts
|
+$5.27M |
Top Sellers
| 1 | -$47.4M | |
| 2 | -$14.2M | |
| 3 | -$10.2M | |
| 4 |
New York State Common Retirement Fund
Albany,
New York
|
-$9.84M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$6.7M |